{
    "clinical_study": {
        "@rank": "161710", 
        "brief_summary": {
            "textblock": "A study evaluating Retisert in patients with age-related macular degeneration"
        }, 
        "brief_title": "A Study to Evaluate Retisert in the Treatment of Patients With the \"Wet\" Form of Age-Related Macular Degeneration", 
        "condition": "Macular Degeneration", 
        "condition_browse": {
            "mesh_term": "Macular Degeneration"
        }, 
        "eligibility": {
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "55 Years"
        }, 
        "firstreceived_date": "March 20, 2002", 
        "id_info": {
            "nct_id": "NCT00032396", 
            "org_study_id": "CDS FL-004"
        }, 
        "intervention": {
            "intervention_name": "Retisert Implant", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Fluocinolone Acetonide"
        }, 
        "keyword": [
            "AMD", 
            "ARMD", 
            "Age-Related Macular Degeneration", 
            "Subfoveal Choroidal Neovascularization", 
            "CNV"
        ], 
        "lastchanged_date": "May 25, 2006", 
        "link": [
            {
                "description": "Control Delivery Systems, Inc. Homepage", 
                "url": "http://www.controldelivery.com"
            }, 
            {
                "description": "Information for Patients on AMD", 
                "url": "http://www.nei.nih.gov/health/maculardegen/armd_facts.asp"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Watertown", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02472"
                }, 
                "name": "Control Delivery Systems, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00032396"
        }, 
        "source": "Control Delivery Systems", 
        "sponsors": {
            "collaborator": {
                "agency": "Bausch & Lomb Incorporated", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Control Delivery Systems", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2001", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2002"
    }, 
    "geocoordinates": {
        "Control Delivery Systems, Inc.": "42.371 -71.183"
    }
}